Lavipharm S.A. engages in the research, development, manufacture, import, marketing, sale, and wholesale of pharmaceutical, cosmetics, and healthcare products to physicians and pharmacists in Greece and internationally. The company offers pharmaceutical products for cardiology, oncology-urology, central nervous system, chronic pain, and self- treatment. It also provides prescription medicines and over the counter (OTC) products, as well as LIFELAB CBD products. The company was founded in 1911 and is based in Paiania, Greece.

Sector

Healthcare

Industry

Drug Manufacturers - Specialty & Generic

CEO

Lavidas, Telemaque

Employees

282

Website

lavipharm.com

IPO Date

1995-11-08

Headquarters

12, Agias Marinas Street, PO Box 59, Paiania 19002, Greece

Socials

NEWSLETTER

View Data Providers

NEWSLETTER

View Data Providers

Gainify provides tools and content designed to help users explore and understand the world of investing. All information available through our platform is for educational and informational use only. It is not intended as financial, investment or legal advice, and should not be treated as a recommendation or endorsement of any investment approach.
Our content is general in nature and does not account for your personal financial circumstances. Any investment decisions you make are your responsibility. We strongly recommend speaking with a licensed financial advisor or professional before acting on any information found on Gainify. Before using Gainify, please review our Terms of Service.

Lavipharm LAVI

Lavipharm Earnings Call Summary

Lavipharm Earnings

Transcripts

Events

About Lavipharm S.A.

Lavipharm
LAVI